Nov 17
|
Chairman of Charles River Laboratories International James Foster Buys 2.3% More Shares
|
Nov 16
|
Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
|
Nov 13
|
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
|
Nov 10
|
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript
|
Nov 9
|
Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023
|
Nov 9
|
Q3 2023 Charles River Laboratories International Inc Earnings Call
|
Nov 8
|
Charles River Laboratories Posts Mixed Q3 Results; Updates 2023 Outlook
|
Nov 8
|
Charles River's (CRL) Q3 Earnings Beat, Margins Decline
|
Nov 8
|
Charles River (CRL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
Nov 8
|
Charles River Laboratories Announces Third-Quarter 2023 Results
|
Nov 6
|
Unlocking Q3 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics
|
Sep 12
|
Long-Term Returns of Billionaire Barry Rosenstein’s Activist Targets
|
Sep 11
|
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
|
Sep 8
|
Charles River (CRL) Down 6.1% Since Last Earnings Report: Can It Rebound?
|
Sep 6
|
Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
|
Sep 6
|
Here's Why You Should Retain Charles River (CRL) Stock Now
|
Sep 6
|
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
|
Aug 30
|
Unveiling Charles River Laboratories International's Value: Is It Really Priced Right? A ...
|
Aug 30
|
Charles River Labs to shut 1 of 3 facilities in South San Francisco
|
May 1
|
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
|